Skip to main content
Equibles

Swiss National Bank

Bank

Position in NUVB — Nuvation Bio Inc.

CIK 1582202 ZURICH, V8
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,765,024
+$888,578 QoQ
Shares Held
486,800
+11.3% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 242 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. NUVB ranks #94 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in NUVB

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,765,024 486,800
2026-03-31 $1,876,446 437,400
2025-12-31 $3,919,104 437,400
2025-09-30 $1,338,660 361,800
2025-06-30 $832,065 426,700
2025-03-31 $750,992 426,700
2024-12-31 $1,135,022 426,700
2024-09-30 $664,329 290,100
2024-06-30 $776,136 265,800
2023-09-30 $345,854 258,100
2023-06-30 $464,580 258,100
2023-03-31 $428,446 258,100
2022-12-31 $541,632 282,100
2022-09-30 $631,904 282,100
2022-06-30 $914,004 282,100
2022-03-31 $1,353,924 257,400
2021-12-31 $2,027,250 238,500
2021-09-30 $2,629,130 264,500
2021-06-30 $2,444,806 262,600